59604 Federal Register / Vol. 69, No. 192 / Tuesday, October 5, 2004 / Notices 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, Member 

Conflict Meeting. 

Date: November 17, 2004. 

Time: 5 p.m. to 8 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz-Carlton Hotel at Pentagon City, 

1250 South Hayes Street, Arlington, VA 

22202. 

Contact Person: Mark Swieter, PhD., 

Health Scientist Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, National Institutes of Health, 

DHHS, 6101 Executive Boulevard, Suite 220, 

Bethesda, MD 20892–8401, (301) 435–1389.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards, 93.278, Drug Abuse National 

Research Service Awards for Research 

Training, 93.279, Drug Abuse Research 

Programs, National Institutes of Health, HHS)

Dated: September 28, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–22311 Filed 10–4–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Current List of Laboratories Which 

Meet Minimum Standards To Engage in 

Urine Drug Testing for Federal 

Agencies

AGENCY: Substance Abuse and Mental 

Health Services Administration, HHS.

ACTION: Notice.

SUMMARY: The Department of Health and 

Human Services (HHS) notifies Federal 

agencies of the laboratories currently 

certified to meet the standards of 

Subpart C of the Mandatory Guidelines 

for Federal Workplace Drug Testing 

Programs (Mandatory Guidelines) 

published in the Federal Register on 

April 11, 1988 (53 FR 11970), and 

revised in the Federal Register on June 

9, 1994 (59 FR 29908) and on September 

30, 1997 (62 FR 51118). A notice listing 

all currently certified laboratories is 

published in the Federal Register

during the first week of each month. If 

any laboratory’s certification is 

suspended or revoked, the laboratory 

will be omitted from subsequent lists 

until such time as it is restored to full 

certification under the Mandatory 

Guidelines. 

If any laboratory has withdrawn from 

HHS National Laboratory Certification 

Program (NLCP) during the past month, 

it will be listed at the end, and will be 

omitted from the monthly listing 

thereafter. 

This notice is also available on the 

Internet at http://workplace.samhsa.gov

and http://www.drugfreeworkplace.gov.

FOR FURTHER INFORMATION CONTACT: Mrs. 

Giselle Hersh or Dr. Walter Vogl, 

Division of Workplace Programs, 

SAMHSA/CSAP, Room 2–1035, 1 Choke 

Cherry Road, Rockville, Maryland 

20857; 240–276–2600 (voice), 240–276–

2610 (fax).

SUPPLEMENTARY INFORMATION: The 

Mandatory Guidelines were developed 

in accordance with Executive Order 

12564 and section 503 of Pub. L. 100–

71. Subpart C of the Guidelines, 

‘‘Certification of Laboratories Engaged 

in Urine Drug Testing for Federal 

Agencies,’’ sets strict standards that 

laboratories must meet in order to 

conduct urine drug testing for Federal 

agencies. To become certified, an 

applicant laboratory must undergo three 

rounds of performance testing plus an 

on-site inspection. 

To maintain that certification, a 

laboratory must participate in a 

quarterly performance testing program 

plus periodic, on-site inspections. 

Laboratories which claim to be in the 

applicant stage of certification are not to 

be considered as meeting the minimum 

requirements expressed in the HHS 

Mandatory Guidelines. A laboratory 

must have its letter of certification from 

HHS/SAMHSA (formerly: HHS/NIDA) 

which attests that it has met minimum 

standards. 

In accordance with Subpart C of the 

Mandatory Guidelines, the following 

laboratories meet the minimum 

standards set forth in the Mandatory 

Guidelines:

ACL Laboratories, 8901 W. Lincoln 

Ave., West Allis, WI 53227, 414–328–

7840 / 800–877–7016, (Formerly: 

Bayshore Clinical Laboratory). 

ACM Medical Laboratory, Inc., 160 

Elmgrove Park, Rochester, NY 14624, 

585–429–2264. 

Advanced Toxicology Network, 3560 

Air Center Cove, Suite 101, Memphis, 

TN 38118, 901–794–5770 / 888–290–

1150. 

Aegis Analytical Laboratories, Inc., 345 

Hill Ave., Nashville, TN 37210, 615–

255–2400. 

Baptist Medical Center-Toxicology 

Laboratory, 9601 I–630, Exit 7, Little 

Rock, AR 72205–7299, 501–202–2783, 

(Formerly: Forensic Toxicology 

Laboratory Baptist Medical Center). 

Clinical Reference Lab, 8433 Quivira 

Rd., Lenexa, KS 66215–2802, 800–

445–6917. 

Diagnostic Services Inc., dba DSI, 12700 

Westlinks Dr., Fort Myers, FL 33913, 

239–561–8200 / 800–735–5416. 

Doctors Laboratory, Inc., 2906 Julia 

Drive, Valdosta, GA 31602, 229–671–

2281. 

DrugProof, Division of Dynacare/

Laboratory of Pathology, LLC, 1229 

Madison St., Suite 500, Nordstrom 

Medical Tower, Seattle, WA 98104, 

206–386–2661 / 800–898–0180, 

(Formerly: Laboratory of Pathology of 

Seattle, Inc., DrugProof, Division of 

Laboratory of Pathology of Seattle, 

Inc.). 

DrugScan, Inc., P.O. Box 2969, 1119 

Mearns Rd., Warminster, PA 18974, 

215–674–9310. 

Dynacare Kasper Medical Laboratories*, 

10150–102 St., Suite 200, Edmonton, 

Alberta, Canada T5J 5E2, 780–451–

3702 / 800–661–9876. 

ElSohly Laboratories, Inc., 5 Industrial 

Park Dr., Oxford, MS 38655, 662–236–

2609.

Express Analytical Labs, 3405 7th Ave., 

Suite 106, Marion, IA 52302, 319–

377–0500. 

General Medical Laboratories, 36 South 

Brooks St., Madison, WI 53715, 608–

267–6225. 

Kroll Laboratory Specialists, Inc., 1111 

Newton St., Gretna, LA 70053, 504–

361–8989 / 800–433–3823, (Formerly: 

Laboratory Specialists, Inc.). 

LabOne, Inc., 10101 Renner Blvd., 

Lenexa, KS 66219, 913–888–3927 / 

800–873–8845, (Formerly: Center for 

Laboratory Services, a Division of 

LabOne, Inc.). 

LabOne, Inc., d/b/a Northwest 

Toxicology, 1141 E. 3900 S., Salt Lake 

City, UT 84124, 801–293–2300 / 800–

322–3361, (Formerly: NWT Drug 

Testing, NorthWest Toxicology, Inc.; 

Northwest Drug Testing, a division of 

NWT Inc.). 

Laboratory Corporation of America 

Holdings, 7207 N. Gessner Rd., 

Houston, TX 77040, 713–856–8288 / 

800–800–2387. 

Laboratory Corporation of America 

Holdings, 69 First Ave., Raritan, NJ 

08869, 908–526–2400 / 800–437–

4986, (Formerly: Roche Biomedical 

Laboratories, Inc.). 

Laboratory Corporation of America 

Holdings, 1904 Alexander Dr., 

Research Triangle Park, NC 27709, 

919–572–6900 / 800–833–3984, 

(Formerly: LabCorp Occupational 

Testing Services, Inc., CompuChem 

Laboratories, Inc.; CompuChem 

Laboratories, Inc., A Subsidiary of 

Roche Biomedical Laboratory; Roche 

Federal Register / Vol. 69, No. 192 / Tuesday, October 5, 2004 / Notices 59605

CompuChem Laboratories, Inc., A 

Member of the Roche Group). 

Laboratory Corporation of America 

Holdings, 10788 Roselle St., San 

Diego, CA 92121, 800–882–7272, 

(Formerly: Poisonlab, Inc.). 

Laboratory Corporation of America 

Holdings, 1120 Stateline Rd. West, 

Southaven, MS 38671, 866–827–8042 

/ 800–233–6339, (Formerly: LabCorp 

Occupational Testing Services, Inc.; 

MedExpress/National Laboratory 

Center). 

Marshfield Laboratories, Forensic 

Toxicology Laboratory, 1000 North 

Oak Ave., Marshfield, WI 54449, 715–

389–3734 / 800–331–3734. 

MAXXAM Analytics Inc.*, 6740 

Campobello Road, Mississauga, ON, 

Canada L5N 2L8, 905–817–5700, 

(Formerly: NOVAMANN (Ontario) 

Inc.). 

MedTox Laboratories, Inc., 402 W. 

County Rd. D, St. Paul, MN 55112, 

651–636–7466 / 800–832–3244. 

MetroLab-Legacy Laboratory Services, 

1225 NE. 2nd Ave., Portland, OR 

97232, 503–413–5295 / 800–950–

5295. 

Minneapolis Veterans Affairs Medical 

Center, Forensic Toxicology 

Laboratory, 1 Veterans Dr., 

Minneapolis, MN 55417, 612–725–

2088. 

National Toxicology Laboratories, Inc., 

1100 California Ave., Bakersfield, CA 

93304, 661–322–4250 / 800–350–

3515. 

One Source Toxicology Laboratory, Inc., 

1213 Genoa-Red Bluff, Pasadena, TX 

77504, 888–747–3774, (Formerly: 

University of Texas Medical Branch, 

Clinical Chemistry Division; UTMB 

Pathology-Toxicology Laboratory). 

Oregon Medical Laboratories, P.O. Box 

972, 722 East 11th Ave., Eugene, OR 

97440–0972, 541–687–2134. 

Pacific Toxicology Laboratories, 9348 

DeSoto Ave., Chatsworth, CA 91311, 

800–328–6942, (Formerly: Centinela 

Hospital Airport Toxicology 

Laboratory). 

Pathology Associates Medical 

Laboratories, 110 West Cliff Dr., 

Spokane, WA 99204, 509–755–8991 / 

800–541–7897x7. 

Physicians Reference Laboratory, 7800 

West 110th St., Overland Park, KS 

66210, 913–339–0372 / 800–821–

3627. 

Quest Diagnostics Incorporated, 3175 

Presidential Dr., Atlanta, GA 30340, 

770–452–1590 / 800–729–6432 

(Formerly: SmithKline Beecham 

Clinical Laboratories, SmithKline BioScience Laboratories) 

Quest Diagnostics Incorporated, 4770 

Regent Blvd., Irving, TX 75063, 800–

824–6152, (Moved from the Dallas 

location on 03/31/01; Formerly: 

SmithKline Beecham Clinical 

Laboratories; SmithKline Bio-Science 

Laboratories)

Quest Diagnostics Incorporated, 4230 

South Burnham Ave., Suite 250, Las 

Vegas, NV 89119–5412, 702–733–

7866 / 800–433–2750 (Formerly: 

Associated Pathologists Laboratories, 

Inc.) 

Quest Diagnostics Incorporated, 400 

Egypt Rd., Norristown, PA 19403, 

610–631–4600 / 877–642–2216 

(Formerly: SmithKline Beecham 

Clinical Laboratories; SmithKline BioScience Laboratories) 

Quest Diagnostics Incorporated, 506 E. 

State Pkwy., Schaumburg, IL 60173, 

800–669–6995 / 847–885–2010 

(Formerly: SmithKline Beecham 

Clinical Laboratories; International 

Toxicology Laboratories) 

Quest Diagnostics Incorporated, 7600 

Tyrone Ave., Van Nuys, CA 91405, 

818–989–2520 / 800–877–2520 

(Formerly: SmithKline Beecham 

Clinical Laboratories) 

Scientific Testing Laboratories, Inc., 450 

Southlake Blvd., Richmond, VA 

23236, 804–378–9130

Sciteck Clinical Laboratories, Inc., 317 

Rutledge Rd., Fletcher, NC 28732, 

828–650–0409

S.E.D. Medical Laboratories, 5601 Office 

Blvd., Albuquerque, NM 87109, 505–

727–6300 / 800–999–5227

South Bend Medical Foundation, Inc., 

530 N. Lafayette Blvd., South Bend, 

IN 46601, 574–234–4176 x276

Southwest Laboratories, 4645 E. Cotton 

Center Boulevard, Suite 177, Phoenix, 

AZ 85040, 602–438–8507 / 800–279–

0027 

Sparrow Health System, Toxicology 

Testing Center, St. Lawrence Campus, 

1210 W. Saginaw, Lansing, MI 48915, 

517–364–7400 (Formerly: St. 

Lawrence Hospital & Healthcare 

System) 

St. Anthony Hospital Toxicology 

Laboratory, 1000 N. Lee St., 

Oklahoma City, OK 73101, 405–272–

7052

Toxicology & Drug Monitoring 

Laboratory, University of Missouri 

Hospital & Clinics, 301 Business Loop 

70 West, Suite 208, Columbia, MO 

65203, 573–882–1273

Toxicology Testing Service, Inc., 5426 

N.W. 79th Ave., Miami, FL 33166, 

305–593–2260

US Army Forensic Toxicology Drug 

Testing Laboratory, 2490 Wilson St., 

Fort George G. Meade, MD 20755–

5235, 301–677–7085

*The Standards Council of Canada (SCC) 

voted to end its Laboratory Accreditation 

Program for Substance Abuse (LAPSA) 

effective May 12, 1998. Laboratories certified 

through that program were accredited to 

conduct forensic urine drug testing as 

required by U.S. Department of 

Transportation (DOT) regulations. As of that 

date, the certification of those accredited 

Canadian laboratories will continue under 

DOT authority. The responsibility for 

conducting quarterly performance testing 

plus periodic on-site inspections of those 

LAPSA-accredited laboratories was 

transferred to the U.S. HHS, with the HHS’

NLCP contractor continuing to have an active 

role in the performance testing and 

laboratory inspection processes. Other 

Canadian laboratories wishing to be 

considered for the NLCP may apply directly 

to the NLCP contractor just as U.S. 

laboratories do. 

Upon finding a Canadian laboratory to be 

qualified, HHS will recommend that DOT 

certify the laboratory (Federal Register, July 

16, 1996) as meeting the minimum standards 

of the Mandatory Guidelines published in the 

Federal Register on June 9, 1994 (59 FR 

29908) and on September 30, 1997 (62 FR 

51118). After receiving DOT certification, the 

laboratory will be included in the monthly 

list of HHS certified laboratories and 

participate in the NLCP certification 

maintenance program.

The following laboratory is 

withdrawing from the NLCP on October 

8, 2004: PharmChem Laboratories, Inc., 

4600 N. Beach, Haltom City, TX 76137, 

817–605–5300 (Formerly: PharmChem 

Laboratories, Inc., Texas Division; 

Harris Medical Laboratory).

Anna Marsh, 

Executive Officer, SAMHSA.

[FR Doc. 04–22351 Filed 10–4–04; 8:45 am] 

BILLING CODE 4160–20–P

DEPARTMENT OF HOMELAND 

SECURITY 

Bureau of Customs and Border 

Protection 

Proposed Collection; Comment 

Request: Canadian Border Boat 

Landing Permit

ACTION: Notice and request for 

comments. 

SUMMARY: As part of its continuing effort 

to reduce paperwork and respondent 

burden, Bureau of Customs and Border 

Protection (CBP) invites the general 

public and other Federal agencies to 

comment on an information collection 

requirement concerning the Canadian 

Border Boat Landing Permit. This 

request for comment is being made 

pursuant to the Paperwork Reduction 

Act of 1995 (Public Law 104–13; 44 

U.S.C. 3505(c)(2)).

DATES: Written comments should be 

received on or before December 6, 2004 

to be assured of consideration.